100+ Free KYSATS Medical Equivalence Examination Practice Questions
Prepare for the Cyprus KYSATS Medical Degree Equivalence Examination (Εξετάσεις για σκοπούς αναγνώρισης ισοτιμίας και αντιστοιχίας των τίτλων σπουδών Ιατρικής που προέρχονται από χώρες που δεν είναι μέλη της Ευρωπαϊκής Ένωσης) exam with instant access — no signup required.
Loading practice questions...
Key Facts: KYSATS Medical Equivalence Examination Exam
3 papers
Modular subject examinations administered across Internal Medicine, Surgery, and Paediatrics (KYSATS / UCY Medical School)
50%
Minimum passing threshold required in each examined subject paper independently (KYSATS regulations)
2 sessions
Biannual examination sittings conducted each year in March and October (University of Cyprus Centre)
Greek only
Exclusive official examination language specified for all papers (KYSATS / UCY)
€85.43
Statutory application fee for initial academic qualification recognition (KYSATS)
Cap. 250
Statutory basis under Article 7(1)(γ) of The Medical Registration Law (Republic of Cyprus)
The KYSATS Medical Equivalence Examination is the statutory assessment in Cyprus for non-EU medical graduates seeking qualification recognition under Cap. 250 art. 7(1)(γ). Run twice yearly (March and October) by KYSATS and the University of Cyprus, it covers Internal Medicine, Surgery, and Paediatrics with a strict 50% pass mark in each paper. Official sittings are Greek-language electronic tests combining multiple-choice and short-answer spot items; this 100-item English MCQ bank is an independent study adaptation, not an official translation or format simulation.
Sample KYSATS Medical Equivalence Examination Practice Questions
Try these sample questions to test your KYSATS Medical Equivalence Examination exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.
1A 58-year-old male presents to the emergency department with acute retrosternal crushing chest pain of 45 minutes' duration radiating to his left jaw and diaphoresis. An immediate 12-lead ECG reveals 3 mm ST-segment elevation in leads II, III, and aVF with reciprocal depression in leads I and aVL. Heart rate is 76 bpm and blood pressure is 134/82 mmHg. What is the most appropriate initial pharmacological antiplatelet therapy before urgent primary percutaneous coronary intervention (PCI)?
2A 64-year-old female with ischemic cardiomyopathy and chronic heart failure with reduced ejection fraction (HFrEF, LVEF 28%) presents for routine outpatient review. She remains in NYHA functional class II on optimal doses of ramipril 10 mg daily, bisoprolol 10 mg daily, and eplerenone 50 mg daily. Her blood pressure is 118/74 mmHg, eGFR is 52 mL/min/1.73 m², and serum potassium is 4.6 mEq/L. Which medication class should be added to complete foundational guideline-directed medical therapy and reduce cardiovascular mortality?
3A 72-year-old male with a history of hypertension is brought to the resuscitation bay with sudden-onset palpitation, severe shortness of breath, and lightheadedness. Blood pressure is 76/48 mmHg, heart rate is 168 bpm and irregularly irregular, respiratory rate is 28 breaths/min, and bilateral basal crackles are audible. The 12-lead ECG confirms atrial fibrillation with rapid ventricular response and no discrete P waves. What is the most appropriate immediate management?
4A 56-year-old male presents with sudden, excruciating tearing chest pain radiating between his scapulae that began 30 minutes ago. On physical examination, blood pressure is 88/54 mmHg in the right arm and 142/86 mmHg in the left arm, with distended jugular veins and distant heart sounds. A bedside transthoracic echocardiogram demonstrates an intimal flap in the ascending aorta and a moderate pericardial effusion with right ventricular diastolic collapse. What is the immediate definitive management strategy?
5A 34-year-old previously healthy woman presents to the primary care clinic with a 3-day history of cough productive of rust-colored sputum, fever of 38.4°C, and right pleuritic chest pain. On examination, blood pressure is 116/72 mmHg, heart rate is 84 bpm, respiratory rate is 18 breaths/min, and oxygen saturation is 98% on room air. Auscultation reveals bronchial breath sounds and crackles over the right lower lung base. Her CURB-65 score is 0. Which antibiotic regimen is the most appropriate first-line outpatient therapy?
6A 68-year-old male with severe chronic obstructive pulmonary disease (COPD) presents with increasing dyspnea, increased sputum volume, and purulence. On physical examination, he is alert but tachypneic at 30 breaths/min, using accessory respiratory muscles. Arterial blood gas (ABG) analysis on room air shows: pH 7.28, PaCO2 62 mmHg, PaO2 54 mmHg, and HCO3- 29 mmol/L. Despite prompt administration of nebulized bronchodilators and systemic corticosteroids, his repeat ABG 45 minutes later shows: pH 7.26, PaCO2 66 mmHg, and PaO2 58 mmHg on 28% Venturi mask. What is the most appropriate next step in management?
7A 54-year-old woman who underwent total knee replacement 8 days ago presents with sudden syncope followed by severe dyspnea and pleuritic chest pain. On arrival, she is diaphoretic, heart rate is 128 bpm, blood pressure is 78/48 mmHg refractory to 1 L of IV saline, and oxygen saturation is 86% on room air. Bedside echocardiography demonstrates acute right ventricular dilatation, severe hypokinesis of the RV free wall with sparing of the apex (McConnell sign), and a small, underfilled left ventricle. What is the most appropriate immediate definitive treatment?
8A 22-year-old female with known brittle asthma presents to the emergency department in acute severe distress. She is unable to speak more than single words, sitting upright, with respiratory rate of 34 breaths/min, pulse 138 bpm, and oxygen saturation 90% on high-flow oxygen. Over the past 60 minutes she has received three back-to-back nebulizations of salbutamol (5 mg) and ipratropium bromide (0.5 mg), along with 200 mg intravenous hydrocortisone. On re-evaluation, wheezing is diminished with poor air entry bilaterally, and peak expiratory flow is 30% of predicted. What is the most appropriate next pharmacological intervention to prevent respiratory exhaustion?
9A 62-year-old male with a history of osteoarthritis on daily naproxen presents with two episodes of melena and hematemesis. On arrival, blood pressure is 108/68 mmHg, pulse is 96 bpm, and hemoglobin is 9.4 g/dL. Following volume resuscitation with crystalloids, which pharmacological therapy should be administered while preparing for upper gastrointestinal endoscopy within 24 hours?
10A 52-year-old male with decompensated alcoholic cirrhosis presents with massive hematemesis. On examination, he is pale and confused, pulse is 118 bpm, blood pressure is 86/52 mmHg, and abdominal examination reveals shifting dullness and prominent caput medusae. In addition to airway protection and cautious blood transfusion targeting a hemoglobin of 7-8 g/dL, which combination of medical therapies should be initiated immediately before emergency endoscopy?
About the KYSATS Medical Equivalence Examination Exam
The Cyprus KYSATS Medical Degree Equivalence Examination (Εξετάσεις Αναγνώρισης Τίτλων Ιατρικής) is the official compensatory written assessment administered by KYSATS in partnership with the University of Cyprus Medical School for graduates of medical schools from non-EU/EEA countries seeking academic recognition of their medical qualifications under The Medical Registration Law, Cap. 250, art. 7(1)(γ). The examination tests three core subjects: Internal Medicine (Παθολογία), Surgery (Χειρουργική), and Paediatrics (Παιδιατρική), with candidates sitting the specific papers designated in their KYSATS referral letter. Official examinations are conducted electronically in Greek; this bank provides an English-language MCQ study adaptation for core medical curriculum review.
Assessment
Three modular electronic papers administered on separate dates during biannual testing sessions (March and October). Candidates take only the subject papers specified in their individual KYSATS referral letter.
Time Limit
Not published
Passing Score
50% in each examined paper
Exam Fee
KYSATS recognition fees: €85.43 to examine an application, €170.86 to re-examine it, €34.17 for the certificate. The sitting fee for the written papers is not published. (Cyprus Council of Recognition of Higher Education Qualifications (KYSATS) & University of Cyprus Medical School)
KYSATS Medical Equivalence Examination Exam Content Outline
Internal Medicine (Παθολογία)
Cardiology, pulmonology, gastroenterology, nephrology, endocrinology, infectious diseases, neurology, hematology, and rheumatology.
General Surgery & Surgical Specialties (Χειρουργική)
Acute abdomen, trauma management, perioperative critical care, gastrointestinal surgery, vascular emergencies, and surgical oncology.
Paediatrics (Παιδιατρική)
Neonatal care, pediatric growth and milestones, childhood infectious diseases, dehydration, pediatric emergencies, and congenital disorders.
How to Pass the KYSATS Medical Equivalence Examination Exam
What You Need to Know
- Passing score: 50% in each examined paper
- Assessment: Three modular electronic papers administered on separate dates during biannual testing sessions (March and October). Candidates take only the subject papers specified in their individual KYSATS referral letter.
- Time limit: Not published
- Exam fee: KYSATS recognition fees: €85.43 to examine an application, €170.86 to re-examine it, €34.17 for the certificate. The sitting fee for the written papers is not published.
Keys to Passing
- Work through all 100 available questions
- Review every answer and explanation
- Track weak areas and revisit them
- Use our AI tutor for tough concepts
KYSATS Medical Equivalence Examination Study Tips from Top Performers
Frequently Asked Questions
What is the KYSATS Medical Equivalence Examination in Cyprus?
The KYSATS Medical Equivalence Examination (Εξετάσεις για σκοπούς αναγνώρισης ισοτιμίας και αντιστοιχίας των τίτλων σπουδών Ιατρικής) is the official academic assessment organized by the Cyprus Council of Recognition of Higher Education Qualifications (ΚΥ.Σ.Α.Τ.Σ.) in partnership with the Medical School of the University of Cyprus. It evaluates whether a medical qualification obtained outside the European Union corresponds academically to the medical degree awarded in Cyprus, fulfilling the statutory requirement under Cap. 250 art. 7(1)(γ) for eventual medical licensure.
Who is required to take the KYSATS Medical Equivalence Examination?
Graduates of medical schools in non-EU/EEA third countries whose medical curricula do not automatically qualify for direct recognition under EU Directive 2005/36/EC are referred to these examinations. KYSATS compares the applicant's programme of study against a model programme of study (πρότυπο πρόγραμμα σπουδών) and, where the degree falls short, specifies make-up subjects; if it falls short by more than 10 courses, correspondence cannot be recognised at all. KYSATS then issues a formal referral letter (παραπεμπτική επιστολή) specifying which of the three subject papers the candidate must pass.
What subjects are tested and what score is needed to pass?
The assessment covers three separate subject papers: Internal Medicine (Παθολογία), Surgery (Χειρουργική), and Paediatrics (Παιδιατρική). To pass, candidates must score at least 50% in each assigned subject paper independently. There is no aggregate score; failing a single subject paper requires retaking that specific paper.
When and how are the official examinations delivered?
Examinations are held twice per year, typically in March (spring session) and October (autumn session). The papers are administered electronically at the University of Cyprus testing facilities under the supervision of the UCY Lifelong Learning & Personnel Selection Examinations Centre (formerly KEPEAA, now KEDIVIM).
In what language is the official examination conducted?
The official examination is conducted exclusively in Greek ('μόνο στην Ελληνική Γλώσσα') and historically includes both multiple-choice and short-answer spot test questions. This practice bank is an English-language MCQ study adaptation created to assist international medical graduates in revising core medical knowledge; it is an independent study tool, not an official translation or format simulation.
What is the statutory role of the Cyprus Medical Council versus KYSATS?
The Cyprus Medical Council (Ιατρικό Συμβούλιο Κύπρου - ΙΣΚ) is the statutory regulatory and licensing authority under The Medical Registration Law (Cap. 250). The Medical Council itself administers no written knowledge examinations. Instead, under Cap. 250 art. 7(1)(γ), the Council requires that non-EU medical qualifications be formally recognized by KYSATS before an applicant can be entered into the Medical Register (Μητρώο Ιατρών).
What are the costs and fees associated with KYSATS recognition?
KYSATS publishes three fees, all of which relate to the recognition application rather than to the written papers: €85.43 to examine an application for recognition of each qualification, €170.86 to re-examine each qualification, and €34.17 to issue the certificate of recognition. Fees are payable at the KYSATS offices in Nicosia or online through JCCsmart. KYSATS and the University of Cyprus do not publish a sitting fee for the examinations themselves; registered candidates are informed directly by the University of Cyprus examinations centre.
What other requirements must non-EU doctors fulfill to practice medicine in Cyprus?
Beyond KYSATS academic equivalence recognition, candidates must apply to the Cyprus Medical Council, provide primary-source credential verification via ECFMG/EPIC (required for non-EU degrees since 1 June 2021), demonstrate Greek language proficiency at Level C1, and provide a clean criminal record certificate issued within the previous 3 months. Cap. 250 art. 7(1)(δ) also requires at least 12 months of post-graduation hospital service including 6 months in pathology and 6 months in surgery; the proviso waives this for a person the Council accepts as holding a specialty under art. 23, or who has served at least 30 months as a doctor in a hospital approved by the Council. The Council must issue a reasoned decision within 3 months of a complete file.